Literature DB >> 24505198

Outcome and significance of silicone oil tamponade in patients with chronic serous retinal detachment.

Pan Sang Kim1, Chang Wook Choi1, Yun Sik Yang1.   

Abstract

PURPOSE: To evaluate the effectiveness of silicone oil tamponade in patients with chronic serous retinal detachment (SRD) persisting for three months after the resolution of ocular inflammation.
METHODS: A total of 17 eyes of 17 patients diagnosed with chronic SRD persisting for three months after the resolution of ocular inflammation and with high risk of phthisis bulbi by secondary ocular hypotony and macular detachment by subretinal fibrous membrane formation were subjected to surgical intervention. Subjects underwent silicone oil tamponade after surgical drainage of subretinal fluid. Retrospective analyses on anatomical and functional success rates were then performed.
RESULTS: Anatomical success with retinal reattachment was observed in ten of the 17 eyes (58.82%), while functional success measured as difference in the best-corrected visual acuity before and after the surgery were logarithm of the minimum angle of resolution (logMAR) 1.95 ± 0.66 and logMAR 1.51 ± 0.66, respectively (p < 0.05).
CONCLUSIONS: This study suggests that, in patients with chronic SRD despite prolonged medical treatment and resolution of inflammation, surgical drainage of subretinal fluid with silicone oil tamponade can achieve anatomical and functional success.

Entities:  

Keywords:  Retinal detachment; Silicone oil tamponade; Subretinal fluid; Uveitis

Mesh:

Substances:

Year:  2014        PMID: 24505198      PMCID: PMC3913979          DOI: 10.3341/kjo.2014.28.1.26

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  12 in total

1.  PCR-positive tubercular retinal vasculitis: clinical characteristics and management.

Authors:  A Gupta; V Gupta; S Arora; M R Dogra; P Bambery
Journal:  Retina       Date:  2001       Impact factor: 4.256

2.  Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.

Authors:  Petros E Carvounis; Andrew C Kopel; Matthew S Benz
Journal:  Am J Ophthalmol       Date:  2006-12-08       Impact factor: 5.258

3.  Serous retinal detachment at the macula in sarcoidosis.

Authors:  P O Watts; S Mantry; M Austin
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

4.  Silicone oil for recurrent vitreous hemorrhage in previously vitrectomized diabetic eyes.

Authors:  S Bodanowitz; N Kir; L Hesse
Journal:  Ophthalmologica       Date:  1997       Impact factor: 3.250

5.  Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months.

Authors:  George Morphis; Cristina Irigoyen; Antonio Eleuteri; Theodor Stappler; Ian Pearce; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-04       Impact factor: 3.117

6.  Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.

Authors:  M Uyama; K Takahashi; J Kozaki; N Tagami; Y Takada; H Ohkuma; H Matsunaga; T Kimoto; T Nishimura
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

7.  Posterior segment manifestations of inflammatory bowel disease.

Authors:  B B Ernst; C Y Lowder; D M Meisler; F A Gutman
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

8.  Bilateral serous retinal detachment in a woman with HELLP syndrome HELLP syndrome and retinal detachment.

Authors:  H Karaguzel; S Guven; A Karalezli; H Erdol
Journal:  J Obstet Gynaecol       Date:  2009-04       Impact factor: 1.246

9.  Surgical drainage of chronic serous retinal detachment associated with uveitis.

Authors:  Anat Galor; Careen Y Lowder; Peter K Kaiser; Victor L Perez; Jonathan E Sears
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

10.  Vogt-Koyanagi-Harada disease in elderly Japanese patients.

Authors:  Chihiro Kiyomoto; Masamoto Imaizumi; Kenichi Kimoto; Hiromi Abe; Satoko Nakano; Kazuo Nakatsuka
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.